by Ram ben Ze'ev
In the most recent episode of The Joe Rogan Experience, JD Vance, President Donald Trump’s vice-presidential pick, voiced his interest in exploring a potential link between the high prevalence of Selective Serotonin Reuptake Inhibitors (SSRIs) use and elevated gun deaths in the United States. He referenced Finland as having the highest rate of private gun ownership in Europe, a belief that, though widespread, is inaccurate—Serbia actually holds this position. Vance's remarks have reignited a conversation on how mental health treatment practices and firearm accessibility might together impact gun violence statistics. Let’s examine this potential correlation and consider how the experiences of other high gun-ownership countries might inform U.S. policies.
The Widespread Use of SSRIs in the United States
In the United States, roughly 13.2% of adults take antidepressants, with SSRIs being among the most commonly prescribed medications. This is notably higher than in countries like Serbia, where only around 1.17% of the population uses antidepressants, and Finland, where 6.76% do. These differences highlight cultural, medical, and societal variances in addressing mental health, with the U.S. more heavily reliant on pharmaceutical solutions.
SSRIs are often prescribed to manage conditions such as depression, anxiety, and obsessive-compulsive disorders. While these medications have been transformative for many, SSRIs are known to have side effects, including increased anxiety, agitation, and impulsivity, which could pose a risk in societies with widespread access to firearms.
Gun Ownership Rates in Comparison
The United States leads the world in civilian gun ownership, with an estimated 120.5 firearms per 100 people—an average of 1.2 guns per person. By contrast, Serbia has about 39.1 firearms per 100 people, followed closely by Finland and Switzerland with 32.4 and 27.6 firearms per 100 people, respectively. These statistics show that although high gun ownership is not unique to the U.S., it is exceptionally prevalent compared to European counterparts. This abundance of firearms provides relatively easy access, which could amplify risks among individuals with mental health challenges, especially those experiencing adverse medication side effects.
Gun Death Rates and Homicide Statistics
The United States recorded 48,204 firearm-related deaths in 2022, underscoring a severe gun violence crisis. The U.S. firearm homicide rate stands at 4.05 per 100,000 people—substantially higher than that of Serbia (0.235), despite its high level of gun ownership. Similarly, Finland and Switzerland, which also have relatively high civilian gun ownership rates for Europe, report significantly lower firearm-related deaths. This discrepancy suggests factors beyond just gun access may be contributing to the heightened U.S. gun death rate.
SSRIs, Mental Health, and Aggression: A Complex Relationship
SSRIs are prescribed to treat mood disorders and anxiety, often linked to emotional distress. However, side effects like agitation or impulsivity, especially in the early treatment stages, could exacerbate aggression in some individuals. If these medications are widely prescribed without close monitoring, their side effects might impact impulsive or violent behaviours, particularly among those who already struggle emotionally and have access to firearms.
While SSRIs provide relief for millions, they require careful oversight to minimize potential risks, especially in a country where firearms are easily accessible. This raises a significant question: Could higher rates of SSRI usage in the United States, coupled with widespread gun access, be factors in the nation’s elevated gun violence statistics?
Potential Correlation Between SSRI Use, Gun Ownership, and Gun Deaths
The U.S., with its high rates of both SSRI usage and gun ownership, also experiences substantially higher gun death rates than Serbia, Finland, and Switzerland, all of which have similar gun ownership levels but lower rates of antidepressant usage. This pattern could suggest a correlation between mental health treatment practices and firearm-related incidents in the U.S., raising concerns about the implications of SSRIs in societies with widespread gun access.
The Role of Other Contextual Factors
While this potential correlation is compelling, it does not establish causation. Gun violence is influenced by a complex interplay of factors, including social and economic stresses, attitudes toward violence, and cultural norms. However, the unique combination of high SSRI usage and extensive gun ownership in the United States presents a distinct variable set that may contribute to its elevated gun death rate. This connection deserves further research to clarify how these factors might interact and influence public health and safety.
Lessons from Other Countries and Moving Forward
Serbia, Switzerland, and Finland demonstrate that high rates of civilian gun ownership do not necessarily correlate with high gun death rates. In these countries, lower rates of SSRI usage and more conservative mental health practices correlate with a stark reduction in firearm fatalities. This contrast with the U.S. invites a closer examination of mental health treatment practices and responsible medication oversight, especially for populations with ready access to firearms.
For the United States, tackling gun violence may require a holistic approach that considers mental health treatment, medication monitoring, and gun access together rather than in isolation. Observing how high gun-ownership nations manage their mental health practices and firearm regulation could offer valuable insights.
The U.S. faces a unique set of circumstances—a culture deeply embedded with both firearm availability and a reliance on antidepressants. Addressing gun violence effectively may require exploring how these factors interconnect and implementing strategies to mitigate risks associated with SSRI usage in a heavily armed society. A renewed focus on these interwoven issues could be a critical step toward a safer future for all Americans.
###
Bill White (Ram ben Ze'ev) is CEO of WireNews Limited, Mayside Partners Limited, MEADHANAN Agency, Kestrel Assets Limited, SpudsToGo Limited and Executive Director of Hebrew Synagogue